Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker

被引：0

作者：

Ida Johansson

Cecilia Nilsson

Pontus Berglund

Martin Lauss

Markus Ringnér

Håkan Olsson

Lena Luts

Edith Sim

Sten Thorstensson

Marie-Louise Fjällskog

Ingrid Hedenfalk

机构：

[1] Lund University,Department of Oncology, Clinical Sciences

[2] Lund University,CREATE Health Strategic Center for Translational Cancer Research

[3] BMC C13,Center for Clinical Research

[4] Central Hospital of Västerås,Department of Oncology

[5] Uppsala University,Department of Pathology

[6] Lund University Hospital,Department of Pharmacology

[7] University of Oxford,Department of Pathology

[8] Linköping University Hospital,undefined

来源：

Breast Cancer Research | / 14卷

关键词：

Estrogen Receptor; Human Leukocyte Antigen; Human Leukocyte Antigen Class; Male Breast Cancer; Male Breast Cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 21 条

[1] Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
Johansson, Ida
Nilsson, Cecilia
Berglund, Pontus
Lauss, Martin
Ringner, Markus
Olsson, Hakan
Luts, Lena
Sim, Edith
Thorstensson, Sten
Fjallskog, Marie-Louise
Hedenfalk, Ingrid
BREAST CANCER RESEARCH, 2012, 14 (01):
[2] Immunohistochemical determination of arylamine N-acetyltransferase 1 (NAT1) as the target of miR-1290 and prognostic biomarker of breast cancer
Endo, Yumi
Yamashita, Hiroko
Takahashi, Satoru
Sato, Shinya
Yoshimoto, Nobuyasu
Asano, Tomoko
Hato, Yukari
Yamaguchi, Mina
Dong, Yu
Toyama, Tatsuya
CANCER RESEARCH, 2015, 75
[3] Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer
Endo, Yumi
Yamashita, Hiroko
Takahashi, Satoru
Sato, Shinya
Yoshimoto, Nobuyasu
Asano, Tomoko
Hato, Yukari
Dong, Yu
Fujii, Yoshitaka
Toyama, Tatsuya
BMC CANCER, 2014, 14
[4] Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer
Yumi Endo
Hiroko Yamashita
Satoru Takahashi
Shinya Sato
Nobuyasu Yoshimoto
Tomoko Asano
Yukari Hato
Yu Dong
Yoshitaka Fujii
Tatsuya Toyama
BMC Cancer, 14
[5] Genotyping human arylamine N-acetyltransferase type 1 (NAT1) -: The identification of two novel allelic variants
Payton, MA
Sim, E
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (03) : 361 - 366
[6] Placental expression of arylamine N-acetyltransferases: Evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2
Smelt, VA
Mardon, HJ
Sim, E
PHARMACOLOGY & TOXICOLOGY, 1998, 83 (04): : 149 - 157
[7] microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
Gasparini, Pierluigi
Cascione, Luciano
Fassan, Matteo
Lovat, Francesca
Guler, Gulnur
Balci, Serdar
Irkkan, Cigdem
Morrison, Carl
Croce, Carlo M.
Shapiro, Charles L.
Huebner, Kay
ONCOTARGET, 2014, 5 (05) : 1174 - 1184
[8] Gene expression profiling of male breast cancer reveals two subgroups distinct from the intrinsic subtypes of female breast cancer
Johansson, Ida
Nilsson, Cecilia
Berglund, Pontus
Lauss, Martin
Ringner, Markus
Olsson, Hakan
Luts, Lena
Thorstensson, Sten
Fjallskog, Marie-Louise
Hedenfalk, Ingrid
CANCER RESEARCH, 2012, 72
[9] Transgenic liver expression of human arylamine N-acetyltransferase NAT2 restores sensitivity of male Nat1/2 null mice to 4-aminobiphenyl-induced liver tumorigenesis
Grant, Denis M.
Brenneman, Debbie
Sugamori, Kim S.
CANCER RESEARCH, 2012, 72
[10] Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures
Hedenfalk, IA
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (13) : 960 - 961

← 1 2 3 →